ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

JSR continues push into contract research

by Michael McCoy
January 1, 2018 | APPEARED IN VOLUME 96, ISSUE 1

The Japanese chemical maker JSR has agreed to purchase the contract research firm Crown Bioscience International for about $400 million. Based in Taiwan, Crown offers patient-derived xenograft and animal models for multiple diseases. JSR expects Crown to have sales this year of about $90 million. JSR previously acquired the contract research and development firms KBI Biopharma, MBL, and Selexis.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment